NEW YORK, Aug 10 (Reuters) – Hims & Hers Health on Monday posted a bigger-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs. Shares of the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Pitt loses QB Mason Heintschel, survives Virginia Tech to stay perfect
Pittsburgh weathered the loss of quarterback Mason Heintschel and a furious Virginia Tech rally to…
Fed may skip October but pull rate hike trigger in December
By Ann Saphir Oct 2 (Reuters) - Federal Reserve policymakers were already leaning against delivering…
Asian Games a 'valuable lesson' for future Olympic bids, says JOC president
VIDEO SHOWS: JAPANESE OLYMPIC COMMITTEE'S PRESIDENT SEIKO HASHIMOTO SPEAKING AT PRESS CONFERENCE IN NAGOYA DURING…
